Nucala received USFDA approval to treat chronic rhinosinusitis with nasal polyps
GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) have approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5),... Read More
FDC launches Favipiravir oral suspension to treat mild to moderate cases of COVID-19
Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19... Read More
Sun Pharma launches a special initiative ‘Sunkalp’ for the welfare of doctors
Posted on16 Jul 2021
Comments0
Sun Pharmaceutical Industries launched a special initiative ‘Sunkalp’ for the welfare of doctors, their families and the community. The company stated that... Read More
Insight on Neurogastrx licensing deal with Daewoong Pharmaceutical to Develop Fexuprazan
Neurogastrx, Inc. has entered into an exclusive license agreement with Daewoong Pharmaceutical Co., Ltd., of Seoul, South Korea, for the development and... Read More
Case Study: Strategic Insight of acquisition of Constellation Pharmaceuticals by MorphoSys
Posted on03 Jun 2021
TagsConstellation Pharmaceuticals, MorphoSys AG, pharma deal, pharma strategic deal, strategic management in pharma
Comments0
MorphoSys AG, and Constellation Pharmaceuticals, Inc. announced that they have entered into a definitive agreement whereby MorphoSys will acquire Constellation for $34.00... Read More
Amryt’s filed Oleogel-S10 NDA for the treatment of Epidermolysis Bullosa
Amryt, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that the U.S.... Read More
Insight on Sun Pharma’s Licensing Agreement with Ferring Pharmaceutical for Caritec in India
Sun Pharmaceutical Industries entered into a licensing agreement with Ferring Pharmaceuticals to commercialise innovative obstetric drug Caritec in India. One of the... Read More
Insight on why Jazz Pharmaceuticals to acquire GW Pharma?
GW Pharmaceuticals announced they have entered into an agreement with Jazz Pharmaceutical. As per the agreement, Jazz to acquire GW Pharma. Both... Read More
CoronaVac received conditional marketing authorization from NMPA China
Posted on10 Feb 2021
Comments0
Sinovac Biotech announced that the China National Medical Products Administration (NMPA) has granted a conditional marketing authorization (CMA) to Sinovac for CoronaVac,... Read More
Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab
Global pharmaceutical company, Sanofi will acquire a clinical-stage biopahrmaceutical company Kymab. Sanofi will acquire Kymab for an upfront payment of approximately $1.1... Read More